TY  - GEN
AU  - Providência,Rui
AU  - Marijon,Eloi
AU  - Albenque,Jean-Paul
AU  - Combes,Stéphane
AU  - Combes,Nicolas
AU  - Jourda,François
AU  - Hireche,Hassiba
AU  - Morais,João
AU  - Boveda,Serge
TI  - Rivaroxaban and dabigatran in patients undergoing catheter ablation of atrial fibrillation
SN  - 1532-2092
PY  - 2015///0415
KW  - Administration, Oral
KW  - Aged
KW  - Anticoagulants
KW  - administration & dosage
KW  - Atrial Fibrillation
KW  - diagnosis
KW  - Benzimidazoles
KW  - Catheter Ablation
KW  - adverse effects
KW  - Dabigatran
KW  - Drug Prescriptions
KW  - Drug Utilization Review
KW  - Female
KW  - Hemorrhage
KW  - chemically induced
KW  - Humans
KW  - Male
KW  - Middle Aged
KW  - Morpholines
KW  - Portugal
KW  - Practice Patterns, Physicians'
KW  - trends
KW  - Prospective Studies
KW  - Risk Assessment
KW  - Risk Factors
KW  - Rivaroxaban
KW  - Thiophenes
KW  - Thromboembolism
KW  - etiology
KW  - Time Factors
KW  - Treatment Outcome
KW  - beta-Alanine
N1  - Publication Type: Journal Article; Observational Study
UR  - https://doi.org/10.1093/europace/euu007
ER  -